Growth Milestones
LENSAR increase global market share from 13 to 16%
LENSAR achieved significant growth milestones during 2020, including an increase in global market share from 13 to 16%, a 10% increase in customer installed base and a 15% increase in procedure volume in their two largest markets, according to the company. “We maintained our leading laser system utilisation position with an average of 430 procedures performed per laser vs. 232 with competitive systems. These successes are a testament to our dedication to bringing ophthalmic surgeons the most advanced and beneficial laser system available today,” said Nick Curtis, Chief Executive Officer of LENSAR. “I am also pleased to report that we remain on track to file the 510K application in the first quarter of 2022 and launch ALLY later that year,” said Mr Curtis.
www.lensar.com
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.